Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Progyny, Inc. Director's Dealing 2020

Dec 16, 2020

31752_dirs_2020-12-15_15aa1ec2-e5d3-4dae-bf85-606381024d9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Progyny, Inc. (PGNY)
CIK: 0001551306
Period of Report: 2020-12-14

Reporting Person: SEIDENBERG BETH C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-14 Common Stock S 38461 $42.00 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 94141 Direct
Common Stock 12026296 Indirect

Footnotes

F1: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 13, 2020.

F2: The shares are directly held by The Seidenberg/Vogel Rev Trust 3/6/03 Paul Vogel (the "Trust"). The Reporting Person is a trustee of the Trust.

F3: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 869,153 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.